Moreover, we examined whether there was a relevant change in NOXA expression post-NAC in breast cancer samples exhibiting features of Therapy-Induced Senescence (TIS), a connection that is still poorly understood in clinical cancer. The gene discussed is PMAIP1; the disease is breast carcinoma.